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Enterohepatic Helicobacters have been shown to inha-
bit the intestine and hepatobiliary tracts and may be
associated with a variety of diseases [1]. The enterohe-
patic Helicobacters were ﬁrst recognized in laboratory
rodents and have been considered a component of the
resident microbiota, or normal ﬂora. However, the role
of enterohepatic Helicobacters in human diseases
remains obscure.
Helicobacter hepaticus, perhaps the most studied mem-
ber of enterohepatic Helicobacter, colonizes the lower
gastrointestinal tract, including the cecum, colon, and
hepatobiliary system of mice [2–4]. Helicobacter hepaticus
infection can cause chronic active hepatitis and typhlo-
colitis in immunocompetent mice and can lead to liver
carcinoma in male mice of susceptible strains [5–9].
Natural and experimental infection with H. hepaticus in
certain immunodeﬁcient mice can induce inﬂammatory
bowel disease [10,11]. Helicobacter bilis was also identi-
ﬁed in inbred mice with chronic hepatitis [12]. Helico-
bacter bilis infection in immunodeﬁcient rodents causes
typhlocolitis and diarrhea [13]. These studies have
prompted the increased use of murine models with
H. hepaticus infection to elucidate the possible roles of
Helicobacter in the development of gastrointestinal
diseases in humans. Helicobacter hepaticus or H. bilis
infection in humans was reported. For example,
patients with chronic liver disease have been reported
to have signiﬁcantly higher levels of antibody to H. bilis
and H. hepaticus compared to healthy subjects [14].
Although the H. pylori urease A gene (nested amplicon)
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Abstract
Background: Since the discovery of Helicobacter pylori, various enterohepatic
Helicobacter spices have been detected in the guts of humans and animals.
Some enterohepatic Helicobacters have been associated with inﬂammatory
bowel disease or liver disease in mice. However the association of these
bacteria with human diseases remains unknown.
Materials and Methods: We collected 126 bile samples from patients with
cholelithiasis, cholecystitis, gallbladder polyp, and other nonbiliary diseases.
Samples were screened for the presence of enterohepatic Helicobacter spp.
using cultures, nested PCR, or in situ hybridization. We tested for antibodies
to H. pylori and H. hepaticus by Western blot analysis.
Results: Attempts at cultivation were unsuccessful. However, H. hepaticus
was detected in bile samples with nested PCR whereas H. bilis was not.
Helicobacter hepaticus in the bile was conﬁrmed by in situ hybridization, but
H. hepaticus from bile samples was coccoid in appearance. We detected
immunoglobulin G antibodies to H. hepaticus in bile samples by Western
blotting. Helicobacter hepaticus was detected in 40 (32%) of total 126 samples
as H. hepaticus positive if at least one of the three methods with nested PCR,
in situ, or Western blotting. Patients with cholelithiasis (41%) and cholecys-
titis with gastric cancer (36%) had signiﬁcantly higher (p = .029) prevalence
of H. hepaticus infection than samples from patients with other diseases.
Conclusion: Helicobacter hepaticus may closely associate with diseases of the
liver and biliary tract in humans.
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H. bilis-16S rRNA genes have only been detected in two
cases, and H. hepaticus has not been detected [15].
These papers indicate that enterohepatic Helicobacter
spp. may also infect in the human.
The aim of this study was to directly detect entero-
hepatic Helicobacter spp. from human bile samples. We
cultured bile samples taken from patients with and
without hepatobiliary diseases to determine whether
Helicobacter spp. were present. We used PCR and
nested-PCR for detecting H. hepaticus or H. bilis.A s
nested-PCR for only H. hepaticus was positive, we tested
the bile samples for in situ hybridization by a probe for
H. hepaticus and for Western blotting by anti-H. hepaticus
antibodies.
Materials and Methods
Bile Samples
This study was approved by the Regional Ethics
Committee of Miyoshi Central Hospital and all patients
provided informed consent. The ﬁnal clinical diagnoses
of the patients were based on clinical imaging ﬁndings
including endoscopic retrograde cholangiopancreato-
graphy, ultrasonogram, and computed tomography or
surgery. Diagnoses included cholelithiasis (n = 60;
mean age 61.2 years from 26 men and 34 women),
cholecystitis and gastric cancer (n = 28; mean age
71.8 years from 19 men and 9 women), gallbladder
polyp (n = 6; mean age 57.2 years from one man and
ﬁve women), or other nonbiliary diseases (n = 32;
mean age 69.2 years from 17 men and 15 women). We
collected a total 126 bile samples from 63 men and 63
women (mean age 65.5 years) who underwent surgery,
endoscopic retrograde cholangiopancreatography, per-
cutaneous transhepatic cholangiography and drainage,
or percutaneous transhepatic gallbladder drainage. Bile
samples were stored at )80  C until processing and
testing.
Bacterial Strains
Helicobacter pylori (ATCC 43504, American Type Culture
Collection) were cultured on brain heart infusion (BHI)
agar supplemented with 7% sterile deﬁbrinated horse
blood at 37  C in a microaerobic chamber (10% CO2,
5% O2, and 85% N2). Helicobacter hepaticus (ATCC
51448) and H. bilis (ATCC 51630) were cultured under
microaerobic conditions using GasPak Plus Hydro-
gen + CO2 system without catalyst (3% H2, 10% CO2,
5% O2, 82% N2) (BD JAPAN, Tokyo, Japan). The mor-
phology (coccoid or rod form) of H. pylori was observed
following culture for a period of 3 days to 2 weeks
using Gram staining. Due to their slow growth rates,
the morphology of H. hepaticus and H. bilis (coccoid or
rod form) were observed using Gram staining following
culture for between 1 and 4 weeks.
Cultures
Bile samples (1 mL) were passed through a Millipore
Filter (0.45 lm pore size, 47 mm diameter) (Millipore
Filter Corp., Billerica, MA, USA) by suction. Based on
the fact that ammonium sulfate has been shown to
allow the coccoid form of H. pylori to go into the loga-
rithmic phase [16] and that bovine serum albumin is a
supplement used for the growth of H. pylori [17], the
ﬁlter was washed under suction using 10 mL of
10 mmol⁄L ammonium sulfate, 10 mmol⁄L NaHCO2
containing 0.9% deoxycholic acid, or phosphate-
buffered saline (PBS) containing 0.1% bovine serum
albumin. Following washing the ﬁlters from all 126 bile
samples were placed onto BHI blood agar plates and
incubated at 37  C in a microaerobic condition as previ-
ously described for 7 days. In addition, a portion of
5–10 lL of bile samples was directly inoculated and
incubated on a BHI blood agar plate.
PCR Ampliﬁcation
DNA was puriﬁed from 100 lL of bile sample using
MagExtractor (TOYOBO Co. Ltd, Osaka, Japan). Prim-
ers for H. bilis, H. hepaticus, and Helicobacter universal
primers were designed by modiﬁcation of primers
which were previously reported from Goto et al. [18]
(Table 1). PCR reactions were conducted in an iCycler
R
(BioRad, Hercles, CA, USA). Reaction mixtures (50 lL
of total volume) contained 1 lmol⁄L of oligonucleotide
primer, 1· PCR buffer (EX Taq buffer), 1 U of EX Taq
polymerase (TAKRA Bio Inc., Osaka, Japan), and
100 ng of template DNA, unless otherwise stated.
Nested PCR was performed on template DNA from
bile samples using H. bilis or H. hepaticus speciﬁc prim-
ers. The second PCR primers were designed to lie
within the PCR products of the Helicobacter universal
primers. The ﬁrst PCR reaction using Helicobacter uni-
versal primers for the DNA samples were preheated at
98  C for 2 minutes and then subjected to 30 cycles
consisting of denaturation at 98  C for 10 seconds, pri-
mer annealing at 55  C using Helicobacter universal
primers for 30 seconds, and extension at 72  C for
1 minute. The second PCR reaction individually used
primers for H. hepaticus or H. bilis, with 5 lL of PCR
products from the ﬁrst PCR, was preheated at 98  C for
2 minutes and then subjected to 30 cycles consisting of
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at 55  C using H. hepaticus primers or H. bilis primers for
30 seconds, and extension at 72  C for 30 seconds.
Samples of 10 lL were separated by electrophoresis on
a 2% of NuSieve agarose gel (FMC Bioproducts Inc.,
Rockland, ME, USA), stained with ethidium bromide,
and visualized under ultraviolet light.
In situ Hybridization
In situ hybridization was performed on nylon mem-
brane using a 3¢-Cy3 labeled DNA probe (GAA ACT
GTT ACT CTG GAG TGT GGG AGA GGT) for position
575–604 of the 16S rRNA gene of H. hepaticus. Bile
samples (100 lL) were diluted to 10-fold with PBS and
were adhered by suction to the nylon membrane using
the Bio-Dot
TM vacuum blotter (BIO-RAD). The mem-
brane was prehybridized with calf thymus DNA in
hybridization buffer containing 5· SSPE (0.2 mol⁄L
phosphate buffer, pH 7.4, 2.98 mol⁄L sodium chloride,
0.02 mol⁄L EDTA), 5· Denhalrdt’s solution, and 0.5%
SDS for 1 hour. Hybridization with the probe was per-
formed at 60  C for 18 hours in a water bath. After
hybridization, the membrane was washed three times
in 0.2· SSPE containing 0.1% SDS (each wash for
15 minutes at 65  C) to remove a nonspeciﬁc binding.
The membrane was observed and photographed using a
Leitz Vario-Orthomat Camera System (Ernst Leitz,
Wetzlar, Germany).
Western Blotting
To prepare for cell lysates for Western blot analysis,
bacteria were cultured in BHI medium with 5% horse
serum in a microaerobic jar with continuous shaking
for 5 days for H. pylori and 10 days for H. hepaticus. Cells
were collected by centrifugation at 6400 · g for 20
minutes. Bacterial cells were washed with PBS and
lysed by ultrasonication by ASTRASON W-380
ultrasonic processor (Heat System-Ultrasonics Inc.,
Farmingdale, NY, USA) in distilled water containing
1 mmol⁄L of phenylmethylsulfonyl ﬂuoride for 20 min-
utes. The cell sediment was centrifuged at 44,280 · g
for 30 minutes, and then the supernatant was used for
Western blot analysis.
Western blotting was performed as previously
described [19]. Bacterial lysates (1 mg⁄mL) of H. pylori
or H. hepaticus were subjected to SDS-PAGE and trans-
ferred to PVDF membranes (Millipore Filter Corp.). The
membranes were incubated with the 126 bile samples
(1 : 100 dilutions) followed by peroxidase-labeled rabbit
anti-human immunoglobulin G (IgG) antibody (DAKO,
Japan, Tokyo) as secondary antibody. Blots were visual-
ized using ECL
TM Western blotting detection reagents
(GE Healthcare Japan, Tokyo). The luminol reaction
was detected with a LAS-1000mini Bio-Imaging
Analyzer System (Fuji Photo Film Co., Tokyo).
Survival of Viable H. hepaticus in Bile Samples
Helicobacter hepaticus (approximately 1 · 10
6 CFU⁄mL in
50 lL) were inoculated into a 24-well culture plate
with 450 lL of PBS, 0.9% deoxycholic acid in PBS, or
in human bile samples obtained from three different
persons. Bacteria were incubated at 37  C in 10% CO2
incubator under100% humidity. Following incubation
for 1, 3, 6, and 24 hours, 10lL samples from each well
were inoculated onto BHI agar containing 5% horse
blood. Plates were incubated at 37  C in microaerobic
condition using GasPak Plus Hydrogen plus CO2 system
without catalyst for 7 days, and the colonies were
counted. Two independent experiments were
conducted with each sample being tested in triplicate.
Statistical Analysis
The association between H. hepaticus infected samples
by patient disease type (cholelithiasis, cholecystitis with
Table 1 Oligonucleotide primers used to amplify 16S rRNA gene
Primer Sequence
a Product size
Helicobacter universal
b Forward CTATGACGGGTATOCGGC 781 bp
Reverse CTCACGACACGAGCTGAC
H. hepaticus Forward GAAACTGTTACTCTG 405 bp
Reverse TCAAGCTCCCCGAAGGG
H. bilis Forward CAGAACTGCATTTGAAACTAC 418 bp
Reverse AAGCTCTGGCAAGCCAGC
aNucleotide sequences for H. hepaticus and H. bilis were cited from GenBank accession number L39122 and U18766, respectively.
bPositions of Helicobacter universal primers were correspond to H. hepaticus 16S rRNA sequence positions at 254–271 for forward primer and at
1018–1035 for reverse primer.
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chi-squared test statistic. A p-value <0.05 was consid-
ered signiﬁcant.
Results
Culture
After 7 days incubation, the surface of the cultured
membrane was scraped and Gram staining was
performed. However no spiral shaped Gram-negative
bacteria were observed by microscopy. In addition, cells
from the membrane were subcultured onto BHI blood
agar plates and incubated under microaerobic condi-
tions at 37  C for 7 days. The majority of colonies that
grew on these plates were Escherichia coli or Enterococcus
spp. Suspicious colonies which looked like members of
the Helicobacter genus were further subcultured onto
BHI blood agar; however, no enterohepatic Helicobacter
were cultured.
PCR
We prepared three sets of primers: Helicobacter univer-
sal, H. hepaticus, and H. bilis (Table 1). To conﬁrm the
speciﬁcity of the primers, DNA puriﬁed from H. pylori,
H. hepaticus, and H. bilis was ampliﬁed using these three
primer sets. When universal Helicobacter primers were
used a 781-bp fragment was ampliﬁed from template
DNA obtained from H. pylori, H. bilis, and H. hepaticus.
The primer sets for H. bilis and H. hepaticus were both
shown to be speciﬁc amplifying a 418-bp and a 458-bp
fragment, respectively (data not shown). The sensitivity
of the H. hepaticus-speciﬁc primers was conﬁrmed. DNA
was extracted from serial dilution of a 100-lL sample of
H. hepaticus culture (10
7 to 10 cells⁄mL in TE buffer) by
boiling at 100  C for 5 minutes. The DNA was ampliﬁed
by PCR using H. hepaticus primers. PCR products were
detected in samples that contained >10
5 cells⁄mL
(Fig. 1A). In addition, we performed nested PCR ﬁrst
using Helicobacter universal primers followed by H. hepa-
ticus-speciﬁc primers. Using nested PCR, we were able
to detect H. hepaticus puriﬁed DNA from samples
containing <10 cells⁄mL (Fig. 1B). The sensitivity of the
H. bilis PCR was the same as that reported for the
H. hepaticus PCR (data not shown). To detect H. hepati-
cus and H. bilis in bile samples PCR was conducted
using Helicobacter universal primers as well as the
H. hepaticus or H. bilis primers. Eight samples were posi-
tive for the ﬁrst PCR using Helicobacter universal primer,
but no products were observed by ﬁrst PCR using
H. hepaticus or H. bilis-speciﬁc primer. Nested PCR on
the PCR products of the Helicobacter universal primers
using the H. hepaticus or H. bilis primers detected only
H. hepaticus DNA, with 16 of the 126 bile samples being
positive for H. hepaticus (Table 2). Examples of positive
and negative samples in the PCR are shown in Fig. 1C.
These positive samples did not correspond to the
eight samples which were positive by PCR using Helico-
bacter universal primers. PCR products of H. hepaticus
(405 bp) were sequenced and conﬁrmed to be 100%
identical to H. hepaticus 16S ribosormal RNA sequence.
In situ Hybridization
Morphology of H. pylori was observed by Gram staining
after 5 days and 2 weeks incubation. As H. hepaticus,
and H. bilis grow more slowly than H. pylori, morpho-
logies of H. hepaticus, and H. bilis were observed after
7 days and 2 weeks. Helicobacter pylori retained its spiral
cells/mL
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Figure 1 Detection of Helicobacter hepaticus DNA in bile samples A
and B: sensitivity and speciﬁcity of nested PCR were conﬁrmed by
DNA which was puriﬁed from serial dilution of cultured H. hepaticus.
(A) Helicobacter hepaticus DNA was detected in samples with
>10
5 cultured cells⁄mL by PCR using hepaticus-speciﬁc primers as a
positive control. (B) Nested-PCR was performed on same samples.
H. hepaticus DNA was detected in samples contained with <10
cultured cells⁄mL by nested PCR when we employed for the ﬁrst PCR
using Helicobacter universal primers and for the second PCR using
hepaticus speciﬁc primers. (C) Helicobacter hepaticus DNA puriﬁed
from bile samples was detected by nested PCR. PCR reactions were
curried out two concentrations of DNAs, sample b is diluted sample a
by 10 times, puriﬁed from bile samples. Positive cases for H. hepaticus
were no. 63, no. 68, no. 70. Positive controls were shown in right
side.
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incubation the coccoid form started to appear, and by
2 weeks all cells were in the coccoid form (Fig. 2A2).
Morphologies of H. hepaticus and H. bilis kept spiral
shaped within 10 days incubation (Fig. 2B1, C1).
Coccoid forms of H. hepaticus and H. bilis were appeared
after 2 weeks incubation. The coccoid forms of three
bacteria had similar morphologies in three strains
(Fig. 2A2, B2, and C2). The cultured bacteria were
transferred to nylon membranes, and hybridized to an
H. hepaticus probe. The H. hepaticus probe reacted with
the logarithmic phase (spiral-shaped) bacteria and with
coccoid forms of H. hepaticus (Fig. 2D1, D2). However
the probe did not react with H. bilis and H. pylori. Bile
samples were adhered to membranes and reacted with
the probe. We observed positive reactions in 25⁄126
samples (Table 2). All of positive samples were in the
coccoid form (Fig. 2E).
Western Blotting
Bile samples were reacted to H. pylori and H. hepaticus
by Western blotting. Reactions were quite weak there-
fore it was difﬁcult to assess positive reactions. Typical
positive and negative cases for H. hepaticus or H. pylori
were shown in Fig. 3. Positive samples for H. pylori
reacted to several antigens (CagA, HSP60, urease A and
B, or 25 kDa protein) of H. pylori. Major antigens were
determined by their locations by speciﬁc antibodies to
CagA (SANTA CRUZ biotechnology Inc., Santa Cruz,
CA, USA), HSP60, Urease A, Urease B, 25 kDa antigen
[19] (data not shown). Positive bile samples for H. hepa-
ticus reacted to the 70 kDa and⁄or 90 kDa antigens of
H. hepaticus. All samples in Fig. 3 were positive for
H. pylori and they reacted some of major antigens of
H. pylori. In no. 1 and no. 2 samples, no band was
detected using H. hepaticus antigens. No. 3 and no. 4
were double positive for H. hepaticus and H. pylori.
Seventeen bile samples in 126 samples were positive for
H. hepaticus (Table 2) and 69 samples were positive for
H. pylori.
Table 2 Number of Helicobacter hepaticus positive samples in 126
samples by three different methods
Method (s)
Number of
positive samples (%)
PCR 16 (12.7)
In situ 25 (19.8)
WB
a 17 (13,5)
Double positive with PCR and In situ 10 (7.9)
Double positive with PCR and WB 4 (3.1)
Double positive with in situ and WB 7 (5.6)
Triple positive with PCR and in situ and WB 2 (1.6)
Positive with one method by
PCR or in situ or WB
40 (32)
aWestern blotting.
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Figure 2 Helicobacter hepaticus was detected by in situ hybridiza-
tion. Morphology was observed after Gram staining of H. pylori (A1:
5 day culture and A2: 2 week culture), H. hepaticus (B1: 7 day culture
and B2: 2 week culture) or, H. bilis (C1: 7 day culture and C2 2 week
culture). Cultured H. hepaticus was adhered to a 0.45-mm nylon
membrane (D1: 7 day culture and D2: 2 week culture as positive
controls). Membranes were hybridized using a cy-3-labeled anti-H.
hepaticus 16S ribosormal RNA probe was hybridized to bacterial RNA.
Morphology was observed by a ﬂuorescent microscopy. (E): A positive
bile sample.
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Figure 3 Anti-H. hepaticus and H. pylori antibodies in bile samples.
Antibodies to H. hepaticus or H. pylori were detected by Western blot
analysis. Bile samples were diluted 10-fold with PBS and reacting with
H. pylori (Hp) and H. hepaticus (Hh) antigens. Protein proﬁles of Hp
and Hh are shown by SDS-PAGE. Most of bile samples reacted to
some of H. pylori antigens of CagA, HSP60, Urease A or B subunit, or
25 kDa protein when the samples were positive for H. pylori (arrows,
samples no. 1, 3, 2, 4). However, H. hepaticus positive samples
(arrows, samples no.3 and 4) reacting to 70 kDa and⁄or 90 kDa
antigens of H. hepaticus (arrow).
Hamada et al. H. hepaticus and Biliary Disease
ª 2009 Blackwell Publishing Ltd, Helicobacter 14: 545–551 549Survival of Viable H. hepaticus in Human Bile
Survival of H. hepaticus in human bile was evaluated.
After 1 hour, CFU of H. hepaticus in PBS had not
decreased. However, CFU of H. hepaticus were markedly
decreased after 3 hours, and no colony was detected
after 5 hours. In contrast, CFU of hepaticus in both bile
samples and 0.9% deoxycholic acid decreased after
1 hour (Fig. 4).
Disease Speciﬁcity
The percentage of H. hepaticus-positive samples by each
method (PCR, in situ, and Western blotting) are shown
in Table 2. We determined samples as H. hepaticus-
positive if at least one of the three methods is positive.
The ratio of H. hepaticus-positive samples in various
diseases was shown in Table 3. The percentage of
patients that were H. hepaticus positive was signiﬁcantly
higher (p = .029) in those with cholelithiasis (41%) and
cholecystitis and gastric cancer (36%) compared with
those with gallbladder polyps (17%) and other diseases
(13%).
Discussion
In general culture of Helicobacter species and in particu-
lar nonpylori Helicobacters is difﬁcult. Indeed, we are
unaware of any reports of the culture of Helicobacter
species from human bile. Despite prolonged incubation
and washing the membrane adhered samples with
buffer to prevent toxicity from deoxycholic acid and
chenodeoxycholic acid all of our culture attempts were
negative for Helicobacter species. Based on our in situ
hybridization studies it was clear that the majority of
H. hepaticus in bile samples were in the coccoid form
and that the numbers present were low. Given this, we
speculate that isolation of logarithmic phase of H. hepa-
ticus from humans may require the use of substantial
liver samples, gallbladder mucosa, or intestinal mucosa.
Seropositivity for H. hepaticus and H. bilis has been
reported in humans. However, there is cross-reactivity
among H. bilis, H. hepaticus, and H. pylori. Nilsson et al.
showed elevated serum antibodies to H. hepaticus as
measured by ELISA after a preabsorption step using
H. pylori antigens, among patients with chronic liver
disease [20]. Patients with chronic liver disease have
increased antibody responses to H. hepaticus and H. bilis
in patients compared to general population adults and
blood donors, and cross-reactivity between H. bilis and
H. pylori was also reported [21]. In this study, our
detection of increased antibody responses to H. hepaticus
with Western blotting analysis showed that IgG anti-
body to H. hepaticus was reacted with 90-kDa and⁄or
70-kDa bands in the positive samples. In contrast, posi-
tive cases for H. pylori reacted with some major H. pylori
antigens which were detected as CagA, HSP60, Urease
A and B subunit, or 25 kDa protein. Vorobjova et al.
indicated that H. hepaticus-positive sera reacted with a
60-kDa band (heat shock protein) after absorption by
H. pylori antigen [22]. Unfortunately, we could not
measure serum antibodies, but this is similar to our
results with bile samples and suggests that the IgG anti-
body in the bile may have originated from the serum.
The pathogenicity of H. hepaticus in humans remains
obscure. Maurer et al. reported that mouse model of
the cholelithiasis was induced by infection with
4.0 
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1.5 
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Figure 4 Survival viable H. hepaticus in the biles H. hepaticus
(approximately 1x10
6 CFU⁄mL in 50 lL) were incubated with 450 lL
of PBS, 0.9% deoxycholic acid in PBS, or human bile samples, which
were obtained from three different persons, at 1, 3 and 5 hours. CFU
of H. hepaticus did not decrease for 1 hour in PBS. The viable bacteria
markedly decreased in the PBS at 3 hours, and they were not
detectable at 5 hours. Viable H. hepaticus in the bile samples were
immediately decreased at 1 hour.
Table 3 Helicobacter hepaticus positive samples in various diseases
Disease
Sample
number
Positive sample
a
number (%)
Cholelithiasis 60 25 (41)
Cholecystitis with
gastric cancer
28 10 (36)
Gallbladder polyp 6 1 (17)
Other disease 32 4 (13)
Total 126 40 (32)
Totally 126 bile samples were collected in Miyoshi Central hospital.
aPositive ratio among various diseases was signiﬁcantly (p = .029)
different by chi-squared test.
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of mice infected with H. hepaticus developed a choles-
terol gallstone [23]. In our study, the prevalence of
H. hepaticus infection in samples from patients with gall-
stones or cholecystitis was higher than in samples from
patients with other diseases. Together these ﬁndings of
both mice models and our human data suggest that
H. hepaticus infection may contribute to the develop-
ment of gallstones.
While H. hepaticus was detected in bile samples only a
limited number were present and these were in the
coccoid form. We showed that high concentration of
deoxycholic acid in bile might be toxic to viable
H. hepaticus (Fig. 4). Despite this, our results suggest
that viable H. hepaticus may be able to infect the liver,
gallbladder epithelium, or intestine of humans.
Although a high prevalence of H. hepaticus was
detected in patients with cholelithiasis and cholecystitis
we were unable to grow H. hepaticus from gallbladder
bile samples. The mechanisms whereby gallstones
develop are unknown but enterohepatic Helicobacter
spp. may be closely associated with this disease in
human.
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